To assess whether TM treatment suppresses the HIF signaling pathway in gynecologic cancer cells, we first determined the effects of TM on HIF-1α protein levels using immunoblotting in ECC-1 human endometrial cancer cells. This evidence concerns the gene HIF1A and endometrial cancer.